Relative contribution of human erythrocyte aldehyde dehydrogenase to the systemic detoxlfication of the oxazaphosphorines

Drug Metabolism and Disposition

Volumn 25, Issue 12, 1997, Pages 1436-1441

  Dockham, Patricia A ^b   Sreerama, Lakshmaiah ^b   Sladek, Norman E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; ALDEHYDE DEHYDROGENASE; ALDEHYDE REDUCTASE; ALDOPHOSPHAMIDE; CYCLOPHOSPHAMIDE; ERYTHROCYTE ENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE; OXAZAPHOSPHORINE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RETINAL; RETINOIC ACID;

ADULT; ARTICLE; CATALYSIS; CONTROLLED STUDY; DRUG DETOXIFICATION; DRUG OXIDATION; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; ISOELECTRIC FOCUSING; MALE; PRIORITY JOURNAL; REDUCTION;

ADULT; ALCOHOL OXIDOREDUCTASES; ALDEHYDE DEHYDROGENASE; ANIMALS; CHICKENS; CYCLOPHOSPHAMIDE; ENZYME ACTIVATION; ERYTHROCYTES; FEMALE; HUMANS; IMMUNOBLOTTING; ISOELECTRIC FOCUSING; ISOENZYMES; MALE; METABOLIC DETOXICATION, DRUG; MIDDLE AGED;

EID: 0031436072     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. N. E. Sladek: Metabolism and pharmacokinetic behavior of cyclophosphamide and related oxazaphosphorines. In "Anticancer Drugs: Reactive Metabolism and Drug Interactions" (G. Powis, ed.). pp. 79-156. Pergamon Press Ltd., UK, 1994.
2. P. A. Dockham, M.-O. Lee, and N. E. Sladek: Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehyde. Biochem. Pharmocol. 43, 2453-2469 (1992).
3. H. W. Goedde and D. P. Agarwal: Pharmacogenetics of aldehyde dehydrogenase (ALDH). Pharmacol. Ther. 45, 345-371 (1990).
4. A. Helander: Aldehyde dehydrogenase in blood: distribution, characteristics and possible use as marker of alcohol misuse. Alcohol Alcohol. 28, 135-145 (1993).
5. M. S. Highley, P. G. Harper, P. H. T. J. Slee, and E. A. De Bruijn: Preferential location of circulating activated cyclophosphamide within the erythrocyte. Int. J. Cancer 65, 711-712 (1996).
6. G. Momerency, K. Van Cauwenberghe, M. S. Highley, P. G. Harper, A. T. Van Oosterom, and E. A. De Bruijn: Partitioning of ifostamide and its metabolites between red blood cells and plasma. J. Pharm. Sci. 85, 262-265 (1996).
7. N. S. Kosower and E. M. Kosower: The glutathione status of cells. Int. Rev. Cytol. 54, 109-160 (1978).
8. F. Michelet, R. Gueguen, P. Leroy, M. Wellman, A. Nicolas, and G. Siest: Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biological variables, and life habits. Clin. Chem. 41, 1509-1517 (1995).
9. L. Pulaski, G. Jedlitschky, I. Leier, U. Buchholz, and D. Keppler: Identification of the multidrug-resistance protein (MRP) as the glutathione-S-conjugate export pump of erythrocytes. Eur. J. Biochem. 241, 644-648 (1996).
10. G. J. R. Zaman, N. H. P. Cnubben, P. J. van Bladeren, R. Evers, and P. Borst: Transport of the glutathione conjugate of ethacrynic acid by the human multidrug resistance protein MRP. FEBS Lett. 391, 126-130 (1996).
11. R. J. Jones, M. Zuehlsdorf, S. D. Rowley, J. Hilton, G. W. Santos, L. L. Sensenbrenner, and O. M. Colvin: Variability in 4-hydroperoxycyclophosphamide activity during clinical purging for autologous bone marrow transplantation. Blood 70, 1490-1494 (1987).
12. B. Das and S. K. Srivastava: Purification and properties of aldose reductase and aldehyde reductase II from human erythrocyte. Arch. Biochem. Biophys. 238, 670-679 (1985).
13. L. Sreerama and N. E. Sladek: Identification and characterization of a novel class 3 aldehyde dehydrogenase overexpressed in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance. Biochem. Pharmacol. 45, 2487-2505 (1993).
14. C. L. Manthey, G. J. Landkamer, and N. E. Sladek: Identification of the mouse aldehyde dehydrogenases important in aldophosphamide detoxification. Cancer Res. 50, 4991-5002 (1990).
15. M. Gassmann, P. Thömmes, T. Weiser, and U. Hübscher: Efficient production of chicken egg yolk antibodies against a conserved mammalian protein. FASEB J. 4, 2528-2532 (1990).
16. K. Inoue, H. Nishimukai, and K. Yamasawa: Purification and partial characterization of aldehyde dehydrogenase from human erythrocytes. Biochim. Biophys. Acta 569, 117-123 (1979).
17. M. M. Bradford: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254 (1976).
18. D. L. Drabkin and J. H. Austin: Spectrophotometric studies. II. Preparations from washed blood cells: nitric oxide hemoglobin and sulfhemoglobin. J. Biol. Chem. 112, 51-65 (1935).
19. H. K. Parekh and N. E. Sladek: NADPH-dependent enzyme-catalyzed reduction of aldophosphamide, the pivotal metabolite of cyclophosphamide. Biochem. Pharmacol. 46, 1043-1052 (1993).
20. J. F. Towell III, J. J. Barboriak, W. F. Townsend, J. H. Kalbfleisch, and R. I. H. Wang: Erythrocyte aldehyde dehydrogenase: assay of a potential biochemical marker of alcohol abuse. Clin. Chem. 32, 734-738 (1986).
21. B. Johansson, H. R. Angelo, J. K. Christensen, I. W. Moller, and P. Ronsted: Dose-effect relationship of disulfiram in human volunteers. II. A study of the relation between the disulfiram-alcohol reaction and plasma concentrations of acetaldehyde, diethyldithiocarbamic acid methyl ester, and erythrocyte aldehyde dehydrogenase activity. Pharmacol. Toxicol. 68, 166-170 (1991).
22. R. D. Johnson, J. Bahnisch, B. Stewart, D. J. C. Shearman, and J. B. Edwards: Optimized spectrophotometric determination of aldehyde dehydrogenase activity in erythrocytes. Clin. Chem. 38, 584-588 (1992).
23. S. Harada, D. P. Agarwal, and H. W. Goedde: Electrophoretic and biochemical studies of human aldehyde dehydrogenase isozymes in various tissues. Life Sci. (Washington, D.C.) 26, 1773-1780 (1980).
24. V. Stocchi, L. Cucchiarini, F. Canestrari, M. P. Piacentini, and G. Fornaini: A very fast ion-pair reversed-phase HPLC method for the separation of the most significant nucleotides and their degradation products in human red blood cells. Anal. Biochem. 167, 181-190 (1987).
25. G. K. Rekha and N. E. Sladek: Inhibition of human class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by the naturally occurring compound gossypol. Adv. Exp. Med. Biol. 414, 133-146 (1997).
26. A. L. Greenbaum, K. A. Gumaa, and P. McLean: The distribution of hepatic metabolites and the control of the pathways of carbohydrate metabolism in animals of different dietary and hormonal status. Arch. Biochem. Biophys. 143, 617-663 (1971).
27. N. E. Sladek, C. L. Manthey, P. A. Maki, Z. Zhang, and G. J. Landkamer: Xenobiotic oxidation catalyzed by aldehyde dehydrogenases. Drug Metab. Rev. 20, 697-720 (1989).
28. A. Helander and M. Curvall: Comparison of blood aldehyde dehydrogenase activities in moist snuff users, cigarette smokers and nontobacco users. Alcohol. Clin. Exp. Res. 15, 1-6 (1991).
29. A. Helander, C. Löwenmo, T. Wikström, and M. Curvall: Inhibition of human blood aldehyde dehydrogenase activity by cigarette-smoke condensate. Life Sci. (Washington, D.C.) 49, 1901-1905 (1991).
30. C. M. Jeavons and A. R. Zeiner: Effects of elevated female sex steroids on ethanol and acetaldehyde metabolism in humans. Alcohol. Clin. Exp. Res. 8, 352-358 (1984).
31. J. F. Brien and C. W. Loomis: Aldehyde dehydrogenase inhibitors as alcohol-sensitizing drugs: a pharmacological perspective. Trends Pharmacol. Sci. 6, 477-480 (1985).
32. N. E. Sladek: Oxazaphosphorine-specific acquired cellular resistance. In "Drug Resistance in Oncology" (B. A. Teicher, ed.), pp. 375-411. Marcel Dekker, Inc., New York, 1993.
33. N. E. Sladek and M.-O. Lee: The use of immortalized mouse L1210/OAP cells established in culture to study the major class 1 aldehyde dehydrogenase-catalyzed oxidation of aldehydes in intact cells. Adv. Exp. Med. Biol. 328, 51-62 (1993).
34. G. Wolf: Multiple functions of Vitamin A. Physiol. Rev. 64, 873-937 (1984).